These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 35589156)

  • 1. Powers, engagements and resultant influences over the design and implementation of medicine pricing policies in Ghana.
    Koduah A; Baatiema L; Kretchy IA; Agyepong IA; Danso-Appiah A; de Chavez AC; Ensor T; Mirzoev T
    BMJ Glob Health; 2022 May; 7(5):. PubMed ID: 35589156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of Medicines Pricing Policies in Ghana: The Interplay of Policy Content, Actors' Participation, and Context.
    Koduah A; Baatiema L; Kretchy IA; Agyepong IA; Danso-Appiah A; de Chavez AC; Ensor T; Mirzoev T
    Int J Health Policy Manag; 2023; 12():7994. PubMed ID: 38618785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of medicines pricing policies in sub-Saharan Africa: systematic review.
    Koduah A; Baatiema L; de Chavez AC; Danso-Appiah A; Kretchy IA; Agyepong IA; King N; Ensor T; Mirzoev T
    Syst Rev; 2022 Dec; 11(1):257. PubMed ID: 36457058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of medicines pricing policies in sub-Saharan Africa: protocol for a systematic review.
    Mirzoev T; Koduah A; Cronin de Chavez A; Baatiema L; Danso-Appiah A; Ensor T; Agyepong IA; Wright JM; Kretchy IA; King N
    BMJ Open; 2021 Feb; 11(2):e044293. PubMed ID: 33622951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value added medicines: what value repurposed medicines might bring to society?
    Toumi M; Rémuzat C
    J Mark Access Health Policy; 2017; 5(1):1264717. PubMed ID: 28265347
    [No Abstract]   [Full Text] [Related]  

  • 6. Developing Nepal's medicines pricing policy: evidence synthesis and stakeholders' consultation.
    Babar ZU; Dulal S; Dhakal NP; Upadhyaya MK; Trap B
    J Pharm Policy Pract; 2024; 17(1):2346222. PubMed ID: 38690551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of national tax policy on local pharmaceutical production in a southwestern state nigeria - qualitative research for the intersection of national pharmaceutical policy on health systems development.
    Obembe TA; Adenipekun AB; Morakinyo OM; Odebunmi KO
    BMC Health Serv Res; 2022 Feb; 22(1):264. PubMed ID: 35220971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of evidence and negotiation in the review of national standard treatment guidelines and essential medicines list: experience from Ghana.
    Koduah A; Asare BA; Gavor E; Gyansa-Lutterodt M; Andrews Annan E; Ofei FW
    Health Policy Plan; 2019 Nov; 34(Supplement_2):ii104-ii120. PubMed ID: 31723963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges to pharmaceutical policymaking: lessons from Australia's national medicines policy.
    Lipworth W; Doran E; Kerridge I; Day R
    Aust Health Rev; 2014 May; 38(2):160-8. PubMed ID: 24589424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards an explanatory framework for national level maternal health policy agenda item evolution in Ghana: an embedded case study.
    Koduah A; Agyepong IA; van Dijk H
    Health Res Policy Syst; 2018 Aug; 16(1):76. PubMed ID: 30075722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How and why pharmaceutical reforms contribute to universal health coverage through improving equitable access to medicines: a case of Ghana.
    Koduah A
    Front Public Health; 2023; 11():1163342. PubMed ID: 37483923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus-related policy-making in Iran: a stakeholder and social network analysis.
    Behzadifar M; Gorji HA; Rezapour A; Rezvanian A; Bragazzi NL; Vatankhah S
    Health Res Policy Syst; 2019 Apr; 17(1):42. PubMed ID: 30992014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knowledge and awareness of policies and programmes to reduce adolescent pregnancy in Ghana: a qualitative study among key stakeholders.
    Ahinkorah BO; Kang M; Perry L; Brooks F
    Reprod Health; 2023 Sep; 20(1):143. PubMed ID: 37740181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating essential medicines for treating childhood cancers: availability, price and affordability study in Ghana.
    Mensah KB; Mensah ABB; Bangalee V; Padayachee N; Oosthuizen F
    BMC Cancer; 2021 Jun; 21(1):683. PubMed ID: 34112117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health system determinants of access to essential medicines for children with cancer in Ghana.
    Boateng R; Renner L; Petricca K; Gupta S; Denburg A
    BMJ Glob Health; 2020 Sep; 5(9):. PubMed ID: 32967979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transitioning to a national health system in Cyprus: a stakeholder analysis of pharmaceutical policy reform.
    Wouters OJ; Kanavos PG
    Bull World Health Organ; 2015 Sep; 93(9):606-13. PubMed ID: 26478624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drawing up the public national Rational Pharmacotherapy Action Plan as part of social and health services reform in Finland: a bottom-up approach involving stakeholders.
    Tahvanainen H; Voipio-Pulkki LM; Hämeen-Anttila K; Närhi U; Mäntyranta T; Holmström AR; Airaksinen M
    BMC Health Serv Res; 2024 May; 24(1):631. PubMed ID: 38750498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How the quality of essential medicines is perceived and maintained through the pharmaceutical supply chain: A perspective from stakeholders in Nigeria.
    Amadi C; Tsui EK
    Res Social Adm Pharm; 2019 Nov; 15(11):1344-1357. PubMed ID: 30509851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of policy actors and contextual factors in policy agenda setting and formulation: maternal fee exemption policies in Ghana over four and a half decades.
    Koduah A; van Dijk H; Agyepong IA
    Health Res Policy Syst; 2015 May; 13():27. PubMed ID: 26022699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of National Drug Pricing Policy 2018 on access to medicines in Lahore division, Pakistan: a pre-post survey study using WHO/HAI methodology.
    Saeed A; Saeed H; Saleem Z; Yang C; Jiang M; Zhao M; Ji W; Aziz MM; Khan FU; Gillani AH; Atif N; Fang Y; Babar ZUD
    BMJ Open; 2020 Oct; 10(10):e034720. PubMed ID: 33033079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.